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Abstract
Background: Combinatorial phage display has been used in the last 20 years in the identification of protein-ligands and
protein-protein interactions, uncovering relevant molecular recognition events. Rate-limiting steps of combinatorial phage
display library selection are (i) the counting of transducing units and (ii) the sequencing of the encoded displayed ligands.
Here, we adapted emerging genomic technologies to minimize such challenges.
Methodology/Principal Findings: We gained efficiency by applying in tandem real-time PCR for rapid quantification to
enable bacteria-free phage display library screening, and added phage DNA next-generation sequencing for large-scale
ligand analysis, reporting a fully integrated set of high-throughput quantitative and analytical tools. The approach is far less
labor-intensive and allows rigorous quantification; for medical applications, including selections in patients, it also
represents an advance for quantitative distribution analysis and ligand identification of hundreds of thousands of targeted
particles from patient-derived biopsy or autopsy in a longer timeframe post library administration. Additional advantages
over current methods include increased sensitivity, less variability, enhanced linearity, scalability, and accuracy at much
lower cost. Sequences obtained by qPhage plus pyrosequencing were similar to a dataset produced from conventional
Sanger-sequenced transducing-units (TU), with no biases due to GC content, codon usage, and amino acid or peptide
frequency. These tools allow phage display selection and ligand analysis at .1,000-fold faster rate, and reduce costs ,250-
fold for generating 10
6 ligand sequences.
Conclusions/Significance: Our analyses demonstrates that whereas this approach correlates with the traditional colony-
counting, it is also capable of a much larger sampling, allowing a faster, less expensive, more accurate and consistent
analysis of phage enrichment. Overall, qPhage plus pyrosequencing is superior to TU-counting plus Sanger sequencing and
is proposed as the method of choice over a broad range of phage display applications in vitro, in cells, and in vivo.
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Introduction
For over two decades, phage display has been used to identify
relevant protein interaction and recognition sites in receptor-
ligand and antigen-antibody binding systems. Because of the
strong predictive value of functional relationships revealed by
specific protein interactions, peptide-protein or antibody-antigen
pairs selected from phage display libraries serve as potential
reagents in a vast range of biomedical and translational
applications [1–4].
A conventional phage display selection typically starts with
exposure of a library to targets of interest in vitro or in vivo. After the
unbound and non-specific binding populations are removed, the
remaining phage particles are recovered by infection and
amplification in host bacteria growing in medium under either a
selective genetic pressure (such as antibiotic resistance) or a
differential identifying color scheme. Host bacteria allow viral
multiplication and generate thousands of newly-formed phage
particles. Upon plating of the host bacteria, lysogenic phage (i.e.,
non-lytic M13-derived) yields bacterial colonies whereas lytic
phage (i.e., Lambda-derived) generates plaques in a bacterial lawn;
each resulting bacterial colony or phage plaque is considered a
transducing-unit (TU). Amplified phage populations serve for
additional selection round(s) and allow enrichment of selective
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8338clones, which may be determined by comparing unselected to
selected libraries through DNA sequencing [1–4]. Thus, the two
most labor- and cost-intensive steps in phage display selection are
(i) the counting of transducing units and (ii) the phage DNA
sequencing (from each individual colony or plaque) to determine
the corresponding peptide sequence of the encoded ligand(s). This
straightforward, if cumbersome, approach has long provided
biomedical findings of value; however, new large-scale technolo-
gies for DNA quantification and sequencing can potentially
overcome some of the practical limitations of the conventional
methodology for phage display selection.
To address this prospect, we have adapted emerging genomic
methodologies to eliminate these two rate-limiting steps: we used
real-time PCR for rapid TU quantification and next-generation
sequencing for large-scale analysis. We present a side-by-side
comparison of all steps and report an integrated experimental
system that greatly streamlines and expedites the entire procedure
while markedly reducing its associated costs about 250-fold
compared to conventional phage display selection. We show that
this new methodology is not only much faster and less labor-
intensive, but allows rigorous quantification with improved overall
accuracy. In as-yet unpublished work, deep amplicon sequencing
of phage particles (i.e., tens of thousands of clones) recovered from
in vivo selections in human patients in a timeframe of up to
72 hours post library administration (in contrast to less than
24 hours for the current methodology), has allowed coverage of
the full repertoire of targeted particles in the analyzed tissue
samples, as shown by saturation curves and the identification of a
panel of previously unrecognized ligand-receptor candidates.
These molecular tools will enable a new generation of high-
throughput and cost-effective phage display selection on an
unprecedented large-scale.
Results
DNA-Based Analysis of Phage Quantification
Development of a high-throughput platform for phage display
selection should ideally be ‘‘bacteria-free’’ with all required steps--
including quantification, internalization, and determination of the
insert sequence--to be largely based on direct nucleic acid analysis,
with an expectation that it might be faster and more cost-effective
than the current methodology. Thus, to validate this platform, all
intermediate steps from phage quantification to sequence
determination were evaluated in a direct, simultaneous (i.e., side-
by-side) comparison with the conventional methodology.
We started by comparing the phage quantification range
obtained through conventional TU-counting versus a quantitative
real-time PCR-based approach (termed ‘‘qPhage’’). For the
qPhage methodology, we designed oligonucleotides targeting the
TetR gene, a common feature to most vectors derived from fUSE5
(Fig. 1A). Both methods (TU-counting and qPhage) were used to
determine phage particle content and titers in multiple serial
Figure 1. Comparison of TU-counting and qPhage. (A) Representation of phage genome and relative location of the cloning site and two sets
of primers used. Primer set #1 targets the Tet
R gene and was used for quantification with real-time PCR; primer set #2 flanks the insert coding for the
peptide displayed in pIII, and served for large-scale sequencing (B and C, respectively). TU-counting and qPhage titration output [determined by
cycle-thresholds (Ct)]; note the limited quantification range for TU-counting relative to qPhage. Comparative results of TU-counting and qPhage
titration of Fd-tet (D) and RGD-4C phage (E) are shown. Asterisk indicates that the high bacterial density prevented accurate TU determination.
doi:10.1371/journal.pone.0008338.g001
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high bacterial colony density prevented accurate determination of
particles at the lower plating dilutions (Fig. 1B), a result mimicking
experiments in vivo when high concentrations of phage are found in
a targeted tissue. In contrast, the qPhage method consistently
detected and linearly quantified phage content in the range of
dilutions evaluated (Fig. 1C). The results of several (n=7)
independent amplifications of such phage dilutions showed a
mean correlation coefficient of 0.99860.002 and a mean
amplification slope of 23.4260.06, an amplification efficiency of
,96%. The direct comparison of both methods, by the use of the
same preparation of 4 points of 10-fold serial dilutions of an
insertless phage [5] and a phage displaying an RGD-4C peptide
targeting av integrins [6-9], showed that qPhage is at least 5-fold
more sensitive than the conventional TU-counting. This increased
sensitivity is derived from the capability of the DNA-based method
to quantify non-infective phage particles. When the same serial
dilutions of RGD-4C phage or Fd-tet phage (Figs. 1D and 1E)
were either plated or quantified by qPhage, each 10-fold dilution
point resulted on average in a proportional variation of 7-fold for
TU-counting and 9.3-fold for qPhage, with an SEM of the
triplicates at all dilutions of 32.5% for TU-counting, versus 7.8%
for qPhage. This direct comparison allowed an evaluation of both
approaches in the detection of pre-determined amounts of phage
particles, as well as measurement of their detection limits and
linear quantification ranges. Based on these direct comparative
results, we conclude that the qPhage methodology is superior and
less human error-prone, particularly in high-density colony plating
settings and under experimental conditions in which suitable
dilutions for TU-counting and relative quantification are difficult
to predict.
Phage Binding and Internalization into Cells
Having shown that the qPhage methodology is better than
conventional TU-counting for quantification, we next sought to
compare these techniques in phage display selection assays [9–17].
Binding of RGD-4C phage [6–10] or insertless control Fd-tet
phage [5] to endothelial cells was performed by the Biopanning
and Rapid Analysis of Selective Interactive Ligands (BRASIL)
method [9] and cell-bound phage was quantified concomitantly
with either TU-counting (Fig. 2A) or qPhage (Fig. 2B). Good
correlation between both methods was observed, indicating that
qPhage recapitulates a state-of-the-art methodology for phage-cell
binding.
Another application of qPhage was the precise quantification of
phage uptake in mammalian cells, thereby allowing analysis of its
internalization dynamics. In the conventional methodology, phage
internalization is achieved only after prolonged incubation,
defined here as an overnight (ON), of phage and cells as detected
by cell membrane permeabilization and visualization with anti-
phage antibodies (Fig. 2C). Given the inherent technical challenges
of staining-based immunodetection, this approach allows one to
determine only whether or not a certain targeting peptide
mediates cell internalization of a phage particle in a non-
quantitative or at best, semi-quantitative manner. In contrast, an
accurate quantification of phage internalization was obtained with
the qPhage method. Traces of phage internalization, even after
very short incubation intervals (,10 min), were detectable by
qPhage but not by immunofluorescence (Fig. 2D). These results
show that the targeted RGD-4C phage internalizes far more than
the Fd-tet phage. Even after prolonged incubation, internalization
of RGD-4C phage was 10
4-fold higher than that of Fd-tet phage
for the same period of time. The detection of internalized RGD-
4C phage after the short incubation interval used was not as
dramatic as that seen after ON incubation, but still points to an
uptake ,10-fold higher than that observed with insertless phage,
which suggests rapid cell internalization of RGD-4C. These results
indicate that internalization of peptide-guided phage can be finely
quantified by qPhage. The DNA-based qPhage methodology
allows full quantification of phage content, binding, and cell
internalization, with a superior performance compared to
conventional TU-counting.
Next-Generation Phage Amplicon Deep Sequencing
To address the other rate-limiting step of conventional phage
display, we reasoned that this DNA-based system would have to
allow determination of the sequences of the encoded ligands
(targeting peptides, unless otherwise specified) in large-scale. We
adapted the next-generation pyrosequencing methodology (454/
Roche) for phage DNA; for proof-of-principle, we used tissues
obtained after intravenous administration of a phage library to
end-of-life patients [18–20]. To determine the capacity of this
approach for the high-throughput generation of phage sequences,
we produced insert-containing amplicons from surgical biopsies of
four human tissues (skin, white adipose tissue, bone marrow, and
skeletal muscle), with oligonucleotides flanking the DNA insert
coding for the peptide in the pIII gene (Fig. 1A).
In a single next-generation run, we generated a total of 319,361
sequences: 251,032 derived from tissues plus another 68,329
derived from the unselected CX7C library before administration.
After filtering (see Methods), the dataset was compared to 3,840
sequences derived from the same samples by conventional Sanger-
sequencing of phage recovered from host bacteria (Table 1).
Our initial concern was to evaluate and, if possible, rule out
eventual discrepancies caused by PCR amplification as a previous
step to phage amplicon deep sequencing. Thus, quality-control
and quality-assurance approaches were undertaken to compare
the DNA sequences derived from both methodologies, including
GC content, codon-usage, and amino acid frequencies in the
encoded peptides as well as the overlap of actual peptides observed
by the two methods and the frequency of homopolymers in inserts
derived from each dataset. After evaluating a non-redundant set of
10,983 nucleotides from Sanger sequences and 55,587 nucleotides
from the pyrosequencing platform, we observed no significant
differences between the two approaches, which showed respective
GC contents of 60.11% and 60.19% (2-sample, unequal variance
T test; t-score=0.437, p-value ,0.3). Strong correlations were
observed for amino acid frequencies and codon utilization when
3,668 (Sanger-derived) or 18,445 (next-generation-derived) amino
acid residues were compared (Pearson correlation analysis
coefficients (r=0.996, p,0.001 and r=0.999, p,0.001, respec-
tively), reinforcing the absence of nucleotide representation biases
from DNA amplified phage (Figure S1 and Table S1). We
conclude that there are no significant differences between phage
DNA sequences recovered by the conventional methodology or by
this alternative DNA-based approach. Moreover, when DNAs
encoding peptide datasets derived from both methods were
compared among human tissues (Fig. 3A) and the non-selected
library (Fig. 3B), we observed that large-scale sequencing
uncovered between 78.6 and 96.3% of the peptides revealed by
TU-counting; whereas between 3.7 and 21.3% of the TU-derived
sequences were not seen by next-generation sequencing, between
25.3 and 97.7% of the peptides revealed by deep sequencing could
not be detected by TU-counting. Finally, no overlaps were seen
when the non-selected phage library was sequenced by either
method, a result indicating the absence of dominant clones prior to
its administration (Fig. 3B).
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here is known for its relatively high error-rate in DNA fragments
containing homopolymers $5nt [21–23] we performed a careful
evaluation of this technical issue by comparing both sequence sets
(i.e., Sanger-based versus 454 pyrosquencing-based). Due to the
determined length of the peptide inserts (21nt), false-positives due
to sequencing errors are not expected. However, a fraction of the
rejected sequences may be false-negatives (i.e., phage containing
valid sequences discarded due to a wrongly assigned non-21nt
insert) derived from homopolymer sequencing errors. To deter-
mine the extent of this potential effect, we investigated the
frequency of homopolymer-containing sequences in both, Sanger-
and 454 pyrosequencing sets. When the accepted sequence sets
derived from both methods were compared (Table S4, online), we
observed that the frequency of homopolymer-containing sequenc-
es to be only slightly higher (and non-statistically significant, Chi-
square test; P-value=0.9955) in the Sanger-dataset (20.4%) than
in the pyrosequencing dataset (18.6%). If one assumes the
percentage of 5nt-homopolymer sequences from the Sanger-set
(20.4%) to be true and takes into account the known15% error
rate of the pyrosequencing platform [22] one reaches an expected
error rate of ,3% (0.20460.15) which is close to the 1.8%
difference observed in the homopolymer frequency between
datasets. Thus, together with other analyses presented in the
Figure 2. Phage binding and internalization assays. Binding of av integrin-binding ligand phage (displaying RGD-4C) or insertless phage to
endothelial cells. Quantification by conventional TU-counting (A) and qPhage (B) are shown. For internalization, endothelial cells were incubated with
RGD-4C phage or insertless phage for short (5 minutes) or long (ON) incubation. Internalized phage particles were detected by immunostaining (C) or
qPhage (D).
doi:10.1371/journal.pone.0008338.g002
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bias against homopolymer-containing inserts is small and non-
significant in our dataset.
Phage Diversity and Motif Enrichment
To determine phage diversity and candidate peptide motif
enrichment, we calculated saturation curves from large-scale
sequences produced from either each tissue and/or unselected
library and showed that the coverage of phage particles present in
these targeted tissues varied from 93.3 to 94.4% of the available
predicted distinct total peptides in each tissue. The high coverage
achieved for all tissues after the sequencing of 40,000 to 63,000
phage amplicons in this round of synchronous selection [29]
strongly suggests that most of the diversity in these tissues has been
covered (Figs. 4A–D). In striking contrast to the targeted tissues,
the sequencing of the non-selected library showed its predicted
diversity, which was far from saturation post evaluation of 5610
4
DNA sequences (Fig. 4E). Finally, we investigated whether this
large dataset would allow the discrimination of more and/or
longer motifs in the distinct tissues than previously reported [20].
Indeed, we observed that many more 3-mer, as well as 4-mer and
5-mer motifs, were revealed by next-generation sequencing (from
10- to 100-fold increment) in comparison to those observed in the
more limited, Sanger-sequencing-derived dataset (Figure S2).
These results show that DNA deep-sequencing through next-
generation approaches (i) is technically feasible and (ii) offers an
unprecedented high-coverage of the displayed ligand repertoire.
All phage sequences produced here are available online (Phage
Sequences File S1).
A Comparative Analysis of Time- and Cost-Effectiveness
We performed a comparative analysis of time and cost required
to reach from 10
3 to 10
6 sequences from a phage library by using
both approaches (Table S6, online). Even with labor costs
excluded from the calculation (i.e., only reagents and plastic-
ware), there is a clear advantage of qPhage plus next-generation
sequencing over TU-counting plus traditional Sanger-sequencing.
Specifically, the generation of 10
3 to 10
6 sequences costs ,250-
fold less than the conventional methodology. This strong cost-
effectiveness remains constant regardless of the increasing
sequence number within this range (Fig. 5A). Moreover, whereas
the generation of 10
3 sequences is only 0.25-fold faster, the
generation of 10
4,1 0
5, and 10
6 sequences will be 13-fold, 130-fold,
and 1,300-fold faster, respectively. Therefore, in contrast to the
high fixed-cost differential, the marked improvement in time-
effectiveness becomes even more evident by the generation of
larger number of sequences, which may actually be required to
cover the full ligand diversity (Fig. 5B).
Discussion
In this study, we address the two least efficient steps of phage
display library selection: quantification and analysis of the
displayed ligands. We introduce an integrated, robust, and readily
available set of DNA-based molecular tools that will markedly
improve combinatorial analysis in vitro and in vivo, and at an
extremely low cost in labor and time.
Phage library quantification is currently scored through phage
infection of host bacteria, serial dilution, and TU-counting (i.e.,
individual colony or plaque). In this process, phage recovery and
library titer depend on a number of factors such as peptide-target
affinity, bacterial toxicity of encoded peptides, viability of phage
after panning and particle recovery, as well as inherent infection
and replication properties of targeted phage clones. Indeed,
certain phage encoded-peptide sequences may be non-accurately
represented due to preferences in the bacteria codon-usage.
Notably, molecular events of host binding, entry, and infection
rates depend on the number of ligands displayed and on the nature
of the hybrid fusion partner; these currently unquantifiable factors
could affect infection and replication capabilities of particular
phage clones and might influence the prospect of uncovering rare
ligands and/or the true library size. Suggested methods, developed
to overcome some of these technical challenges include bacterial
infection-independent procedures, such as enzyme-linked immu-
nosorbent assay (ELISA) with antibodies that bind specifically to
the phage coat [24] and/or phage-DNA-based approaches such as
quantitative-PCR [25-26]. However, biochemical approaches
clearly still lack the required sensitivity when phage titers are
low. Moreover, the concept of ‘‘high-throughput’’ pyrosequencing
of phage display libraries has now evolved from a very complex
Table 1. Sequence datasets derived from conventional and DNA-based phage display selection.
TU-counting & Sanger Sequencing qPhage & Next-generation sequencing
Sample
Total raw
sequences
Sequences
remaining
after
eliminating
inserts ?21
nt (%)
Sequences
remaining
after
eliminating
non-NNB
inserts (final
dataset)
Distinct
nucleotide
sequences
Distinct
peptide
sequences
Total raw
sequences
Sequences
remaining
after
eliminating
inserts ?21
nt (%)
Sequences
remaining
after
eliminating
non-NNB
inserts
Sequences
remaining
after
eliminating
singletons
(final
dataset)
Distinct
nucleotide
sequences
Distinct
peptide
sequences
Bone
marrow
1056 (100) 979 (92.7) 953 (90.2) 555 553 55,350 (100) 39,847 (72) 37,421 (67.6) 37,049 (66.9) 2541 2539
Fat 672 (100) 648 (96.4) 625 (93) 357 356 56,543 (100) 46,356 (82) 43,548 (77) 43,439 (76.8) 460 459
Muscle 1056 (100) 1008 (95.5) 974 (92.2) 522 522 78,157 (100) 65,512 (83.8) 61,005 (81.2) 60,872 (77.9) 1014 1011
Skin 1056 (100) 1029 (97.4) 1002 (94.9) 496 496 60,982 (100) 49,332 (80.9) 46,166 (75.7) 46,032 (75.5) 979 976
CX7C
library
N/A N/A N/A N/A N/A 68,329 (100) 57,089 (83.6) 49,252 (72.1) 49,252* (72.1) 44,618 44,606
TOTAL** 3840 (100) 3664 (95.4) 3554 (92.6) 1289 1285 319,361 (100) 258,163 (80.8) 237,392 (74.3)
*The final dataset for the CX7C reads includes singletons.
**Not including sequences from the non-injected CX7C library for TU counting.
doi:10.1371/journal.pone.0008338.t001
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PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8338Figure 3. Overlap of sequences revealed by Sanger sequencing and next-generation pyrosequencing. Venn diagrams represent the
peptides revealed by Sanger sequencing (purple) and large-scale next-generation pyrosequencing (salmon) in tissues such as bone marrow, fat,
muscle, skin (A) or the non-selected CX7C library (B). The dark-pink area represents sequences found by both approaches. Numbers indicate the total
peptides in each group and their percentage relative to TU-counting (purple and overlap areas) or relative to next-generation sequencing (salmon-
colored area). No overlap was seen for the non-administered phage library sequences, produced by both methods. Circle sizes are proportional to the
number of sequences revealed by each strategy.
doi:10.1371/journal.pone.0008338.g003
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2 amplicons [27–28] to a far
easier technique that enables the sequencing of 10
6 amplicons as
presented here. Finally, quantitative-PCR plus next-generation
sequencing methodologies have not as yet been systematically
compared to TU-counting plus Sanger sequencing in terms of
speed, cost, and--most importantly--accuracy.
The next-generation phage display approach introduced here
includes DNA-analysis of clones from the initial quantification
steps to the final large-scale sequencing, which are relatively much
faster and far less expensive. Replacement of bacterial overnight
growth and TU-counting with DNA extraction and qPCR not
only permits the quantification of non-infective/degraded phage,
but it also yields phage homing results in only a few hours after
tissue removal, simultaneously for dozens of samples in parallel. In
real-time PCR phage quantification (qPhage), reproducible
quantification was attained over a broad concentration range
and was linear over at least eight orders of magnitude, far better
than with the conventional approach and also much more
sensitive than real-time PCR phage quantification reports [25–26].
Our qPhage strategy allows fast and precise validation of target
tissue-specificity in the homing of selected phage or in large-scale
evaluation of dozens of samples, which is particularly appealing for
studies in vivo, including patients [29–30]. These goals are
reachable with only small design modifications through simulta-
neous administration of multiple independent targeted phage
particles in a single animal, followed by specific detection of each
one with appropriate primers or probes in a multiplexed PCR.
After homing validation, peptides shown after sequencing
Figure 4. Saturation plots of peptide diversity coverage after next-generation sequencing. The plot shows the number of distinct
peptides observed in bone marrow (A), fat (B), muscle (C), skin (D) or the non-selected library (E), as a function of the total number of sequences
evaluated for each tissue after filtering. All tissues investigated attained or nearly attained saturation (as determined by the predicted number of
distinct peptides in each tissue), whereas nothing approaching saturation was observed for the unselected library (straight line).
doi:10.1371/journal.pone.0008338.g004
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to a particular target tissue, can be considered further as promising
probes to be developed as agents for imaging and drug delivery in
normal or tumor target sites.
Minor drawbacks remain. Host bacteria are still required for
phage library generation and amplification between screening
rounds; given the phage life cycle, this is unlikely to change.
Another potential drawback is the need to re-clone the phage of
interest (if desired), after its displayed peptide is determined.
Nevertheless, deep sampling of the targeted peptide repertoire
leads to a more reliable phage selection, and the regeneration of
the selected particle(s) of interest can easily be accomplished with
straightforward cloning protocols.
After titration with qPhage, the extracted DNA can be used
directly for high-throughput determination of the displayed ligands
(i.e., peptides or antibodies). In our tests, the generation of a large
number of sequences allowed good coverage of the repertoire in all
tissues studied, and included most of the sequences derived from
conventional TU-counting. The availability of a larger nucleotide
sequence dataset derived from high-throughput sequencing has
also allowed the adoption of more stringent criteria to validate
sequences. For example, we require that a peptide-encoding phage
insert is accepted only if its sequence occurs at least twice, leading
to the exclusion of singletons from the final dataset; such a ‘‘two-
hit requirement’’ reduces sequencing errors in the final dataset of
large-scale DNA sequencing-based approaches [31–32], and
sharply increases our confidence in the displayed peptide list.
This stringent criterion is not applicable to extremely diverse
datasets in which repeats are not expected (i.e., first-round
selection or library sequencing) or in reduced sequence datasets
that are not large enough to cover the entire phage diversity;
indeed, in such cases, the presence of sequencing errors or artifacts
may be one of the factors potentially explaining why large-scale
sequencing may not necessarily exhaust smaller sequence data sets.
As the new methodology proposed here is PCR-based (in
contrast to a host bacteria-dependent approach), a number of
potential advantages and disadvantages emerge. In general, a
PCR-based approach is capable to reveal real binding peptides
whose representation may be negatively impacted by the
requirement of bacterial infection and multiplication. On the
other hand, such PCR-based approach may acquire background
noise due to errors in library construction or assembly of non-
infective phage particles. Our analysis shows that most of the
rejected sequences shown in Table 1 are derived from ‘‘empty’’
phage particles or amplification artifacts. However, the bioinfor-
matic filters implemented here have allowed the prompt
identification and discarding of these artifacts, revealing the
relevant sequences in an unprecedented scale.
As the conventional phage display approach has long been
validated, a central concern of this work was to evaluate whether
any biases were introduced in the new steps that produced the
amplicons to be sequenced. Our comparative analysis based on
GC content and homopolymer frequency in the inserts, as well as
codon usage, and residue or peptide frequencies and overlaps
indicated that (i) there was no preferential amplification of certain
inserts but (ii) both datasets share essentially the same sequence
properties. As the sequencing of homopolymer-containing regions
is a well-known limitation of the 454-Roche pyrosequencing
platform used here, this issue was investigated in detail. As
presented in the online Supplementary Tables, the rejected 454
sequence-dataset contains more homopolymers than the accepted
454 sequence-set (chi-square test, P,0.001; Table S2) and the
more abundant classes of homopolymer-containing sequences
(frequency .3) appear to be somewhat under-estimated (Table
S3). This suggests that insert sequences containing homopolymers
.5nt are under-estimated after 454-pyrosequencing. However,
when all accepted sequences were evaluated (Table S4), we
observed a non-statistically significant trend for a reduced
frequency of homopolymers $5 in the 454-derived dataset when
compared to the Sanger-derived sequence set (chi-square test,
P=0.9955). The fact that both datasets are similar in terms of
homopolymer-containing sequences is likely due to a simple fact.
After PCR, each phage is amplified generating millions of copies
of the original molecule. A certain percentage (,15%) of the
homopolymer-containing amplicons, will not be correctly se-
quenced by 454. However, due to the massive capability of this
approach, enough molecules will still be correctly sequenced and
Figure 5. Analysis of cost and time required to generate phage
sequences using Sanger- or 454-pyrosequencing methods. Cost
(A) and time (B) to generate sequences with Sanger-sequencing of
individual TU (red) versus DNA amplification (qPhage) followed by next-
generation sequencing (blue). Data and estimates used for this analysis
are presented in Table S6 online.
doi:10.1371/journal.pone.0008338.g005
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pyrosequencing and Sanger) will be similar when the distinct sets
of homopolymer sizes are considered.
To reinforce the similarity of both datasets, when sequences
derived from both DNA sequencing methods (N=1645) or
sequences exclusively found by 454-pyrosequencing (N=1202)
were compared, we observe no significant differences in the
frequency of homopolymers of all sizes (4 to 7 repeated bases). The
comparison of homopolymer-containing inserts between these
large groups and the group of sequences exclusively found by
Sanger-sequencing is not informative, as it lacks precision due to
its relatively small size (N=87, compared to .1000 for the other
groups). However, it is interesting to note that the frequency of
homopolymers in sequences found only by the Sanger method was
higher for all classes of homopolymer sizes. This effect may be real,
but is certainly small as we can see from the small size of this group
(Table S5).
As noted above, the sequencing of homopolymers is an
established technical issue for the pyrosequencing methodology.
However, from the analysis presented here, we can conclude that
this technical limitation has only had a very small effect on the
universe of phage particles revealed by the large-scale approach.
As the 454-method allowed a high coverage of the Sanger dataset
for all tissues evaluated (ranging from 78.6 to 96.3%), and it also
uncovered a significant fraction of peptides (25.3 to 97.7%) not
revealed by the low-throughput Sanger-sequencing approach, we
conclude that the benefits of this approach certainly compensate
the known disadvantages and challenges of this particular
sequencing platform. As demonstrated for other platforms (such
as the SOLiD, Applied Biosystems), technical alternatives exist for
the particular sequencing of homopolymeric-rich regions. In the
future, the integrated approach presented here may eventually be
chosen for use with alternative high-throughput sequencing
approaches other than the one developed by 454-Roche.
The large sequence dataset presented here has covered over
90% of the phage diversity of all human tissues we investigated
and has provided a high-confidence list of tissue-specific ligands.
Sets of high-confidence tissue-specific peptides along with
improved statistical analysis of longer motifs can be undertaken
after the sequencing of phage DNA recovered from a large
number of tissues, as well as from specific tissue samples recovered
by micro-dissection from paraffin-embedded tissues. In fact, large-
scale sequencing of naı ¨ve (unselected and unamplified) libraries
may--for the first time--provide an accurate measurement of their
size (i.e., number of unique sequences), a result allowing the
empiric (rather than theoretical) demonstration of the true
randomness of insert sequences. In this study, it should be noted
that we used targeting peptides for validation, but there is no
reason that antibodies would not be as effective. Indeed, one might
speculate that the DNA-based approaches introduced in this study
will eliminate the need for ‘‘helper’’ phage for phage antibody-
display selection, and finally enable its in vivo application.
One technical aspect merits an additional brief commentary.
Next-generation sequencing approaches are being improved
constantly, and the newest chemistry platforms [such as SOLiD
TM
(Applied Biosystems) or Illumina Genome Analyzer (Illumina,
Inc.)] may actually permit the generation of .100 million
sequencing ‘‘reads’’ per run without the inherent challenge of
homopolymer sequencing of this pyrosequencing platform. For
both sequencing technologies, a major limitation is the short
length of possible DNA analytes (,100 nucleotides), which may
prove suitable for combinatorial phage libraries (displaying small
peptides). Nevertheless, because the accuracy and cost-effective-
ness of such methods has not been vetted, it remains to be
determined whether other massive sequencing platforms may
eventually replace the platform used here.
Technological advances have already brought about a new era
for genomics, epigenomics, and transcriptome studies. We predict
the same will happen for phage display analysis. We show that the
integration of DNA-based quantification and large-scale sequenc-
ing methodology presented here produces unbiased data and
allows the full determination of the whole pool of ligand sequences
available after ‘‘n’’ rounds of selection. Our results show that in
tandem qPhage quantification and next-generation DNA sequenc-
ing will set a new gold standard for phage display for accuracy,
running time, diversity coverage, and cost-effectiveness. Overall,
the enabling platform introduced and optimized in this work is
superior to TU-counting plus Sanger sequencing. As such, it may
become the method-of-choice for a broad range of phage-display
applications in silico, in cells, and in vivo; this will be particularly the
case if the extreme molecular diversity observed during large-scale
screenings in patients is considered.
Materials and Methods
Ethics Statement
This study design was reviewed and approved by the
Institutional Review Board of the University of Texas M. D.
Anderson Cancer Center and followed a pre-established ethics
framework [18–19].
Phage Preparation
Insertless Fd-tet [5] or RGD-4C phage [6–10] were amplified
overnight (ON) at 37uC from a single MC1061 E. coli as described
[1]. Phage particles were precipitated with ice-cold phosphate-
buffered saline (PBS) containing 15% NaCl and PEG 8000 for
1 hour, centrifuged for 20 minutes at 4uC at 10,400 g, re-
suspended in 5 ml sterile PBS, and again precipitated in ice-cold
PBS containing 15% NaCl and PEG 8000 for 30 minutes. The
final pellet was re-suspended in 100 ml sterile PBS and centrifuged
for 2 minutes at maximum g force, and the supernatant was sterile
filtered.
Cell Binding and Internalization Assays
Bone marrow-derived endothelial cells [33] were incubated (10
5
cells in 100 ml) with Fd-tet or RGD-4C phage (10
9,3 610
9, and
1610
10 TU) in ice-cold DMEM containing 3% BSA for 3 hours.
Cell suspensions were placed in Eppendorf tubes and centrifuged
at 10,000 g for 10 minutes through an aqueous-organic interface
[9,16,17,29]. Cell pellets carrying membrane-bound phage were
resuspended in 100 ml of PBS. Phage titers were quantified by TU-
counting or qPhage.
Cells were seeded onto 12-well plates (10
5 cells/well) ON,
blocked with Dulbecco’s modified Eagle’s medium (DMEM)
containing 30% fetal bovine serum (FBS) at 37uC and incubated
with 4610
8 TU of phage in DMEM containing 2% FBS (400 ml
of a 2610
9 TU/ml solution). Internalized phage were detected
with a rabbit anti-bacteriophage antibody (Sigma) and Cy3-
conjugated anti-rabbit antibody or were quantified by qPhage
after DNA extraction.
Patient Tissue Collection
After surrogate written informed consent was obtained from the
legal next of kin [18,19,20], short-term intravenous infusion of
phage was performed as described [20] followed by representative
tissue biopsies of skin, fat-tissue, bone marrow and skeletal-muscle.
Besides the screening reported here, which derived from biopsies
taken from a single individual, the library was previously
Next Generation Phage Display
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selection methodology [29]. Biopsy samples served for simulta-
neous histopathology analyses, host bacterial infection, qPhage,
and next-generation sequencing.
DNA Extraction and qPhage
DNA extractions were performed with DNeasy (Qiagen). Phage
content was determined by quantitative PCR (qPCR). PCR
templates consisted of 5 ml of a 1:20 dilution of DNA, 1x Power
SYBR Green PCR Master Mix (Applied Biosystems) and
3.75 pmol of each oligonucleotide primer (fUSE5F1: 59-
TGAGGTGGTATCGGCAATGA-39 and fUSE5R1: 59-GGAT-
GCTGTATTTAGGCCGTTT-39) directed to the amplification
of a fragment of the Tet
R gene, in a final reaction volume of 15 ml.
The program consisted of 50uC for 2 minutes, 95uC for 10
minutes, followed by 40 amplification cycles of 95uC for 15
seconds and 60uC for 1 minute. Standard curves were generated
with serial phage dilutions (from 3 to 3
8 plasmids) for each run.
Each point of the curve and each sample DNA were amplified in
triplicates. The standard curve was calculated by a linear
regression analysis and serial dilutions. Amplification efficiency
(AE) of each PCR cycle was calculated from the slope (s) of the
standard curve by the equation: AE=10
1/(2s).
Phage DNA Amplification for Next-Generation DNA
Sequencing
The amplification of the insert-containing region in the pIII
gene was performed with the oligonucleotide set fUSE5454F: 59-
CGCAATTCCTTTAGTTGTTCC-39 and fUSE5454R: 59-
TGAATTTTCTGTATGAGGTTTTGC-39. The reaction mix
consisted of 6 pmol of each primer, and 12.5 ml of the 2x Phusion
hot-start high-fidelity DNA polymerase mix (Finnzymes) in 25 ml
final volume. Amplifications were performed with a high-fidelity
DNA polymerase mix. Cycles varied from 20- 25, and the number
of reaction tubes varied from 2–6, according to the amount of
phage available in each sample. Resulting amplicons (12–18 mg)
served for adaptor ligation and next-generation sequencing with
the FLX platform (Roche/454). All sequences described here are
presented in a Supporting Information file accompanying this
paper, available on line.
Bioinformatics
DNA sequencing data were filtered to keep only sequences
expected from a 21-nt inserts (termed NNB) of a CX7C library.
Due to the much larger-scale nature of our sequencing approach,
we adopted stringent criteria for accepting DNA sequencing reads;
we applied a singleton-elimination filter where sequences that
appeared only once in the whole dataset were not considered. This
filter cannot be used in datasets derived from Sanger-sequencing,
due to their relatively small size, or in non-selected CX7C library
datasets, where only singletons are expected. Tests were performed
to compare the similarity of Sanger- and next-generation
sequencing-derived datasets in terms of peptide composition, GC
and homopolymer content, codon usage, and residue frequency.
Saturation plots were obtained by randomly shuffling the order of
the filtered nucleotide or peptide sequences, and by calculating the
number of distinct accumulated sequences at every 30
th sequence.
We defined coverage as the percent ratio between the number of
observed distinct peptides and the total number of predicted
distinct peptides in each tissue as estimated with EstimateS [34].
Three estimators were used: abundance-based coverage estimator
(ACE), incidence-based coverage estimator (ICE), and CHAO 1
mean [35]. The adopted total number of predicted distinct
peptides per sample was the average of these three estimates. Data
processing scripts were written in Perl v5.8 and analyses were done
with The R Project for Statistical Computing R-2.6.2.
Supporting Information
Figure S1 The amino acid frequency association between
Sanger and next-generation pyrosequencing phage data was
evaluated by applying a chi-square test, which indicated a
significant association between both methods (p,0.001). Pearson
correlation analysis indicated a strong positive correlation between
sequences obtained by both approaches (r=0.996, p,0.001).
Found at: doi:10.1371/journal.pone.0008338.s001 (1.41 MB TIF)
Figure S2 Enriched motifs revealed by Sanger-sequencing and
next-generation sequencing. The graph shows the number of
distinct, statistically significant (Fisher’s exact test, one-sided,
P,0.05) tri, tetra, and penta amino acid motifs enriched in all
tissues, after their frequencies were compared between every target
tissue and the non-selected phage display library. Motifs derived
from Sanger-sequencing are shown in the white bars.
Found at: doi:10.1371/journal.pone.0008338.s002 (0.84 MB TIF)
Table S1 Codon usage: TU-counting versus pyrosequencing.
The codon usage frequency between both approaches was
evaluated by applying a chi-square test, which indicated a
significant association between both methods (p=0.004). Pearson
correlation analysis indicated a strong positive correlation between
pyrosequencing and colony-counting derived sequences (r=0.999,
p,0.001).
Found at: doi:10.1371/journal.pone.0008338.s003 (0.10 MB
DOC)
Table S2 Homopolymer-containing sequences in rejected- and
accepted-454-pyrosequencing datasets*. *The null-hypothesis that
there is no significant difference between the rejected and accepted
sets in terms of the homopolymer-containing sequences that they
contain can be rejected based on a Chi-square test (P-
value=0.000001). However, one should also note that the
fractions for 4-mers are very close, suggesting that this effect is
noticeable for k-mers with k=5 or greater.
Found at: doi:10.1371/journal.pone.0008338.s004 (0.03 MB
DOC)
Table S3 Homopolymers ($5 nt) in rare, medium, or abundant
frequency groups.
Found at: doi:10.1371/journal.pone.0008338.s005 (0.03 MB
DOC)
Table S4 Homopolymer-containing inserts in the accepted
sequence datasets*. *Chi-square test, P=0.9955.
Found at: doi:10.1371/journal.pone.0008338.s006 (0.03 MB
DOC)
Table S5 Homopolymers in inserts found by each or both
sequencing methods.
Found at: doi:10.1371/journal.pone.0008338.s007 (0.03 MB
DOC)
Table S6 Estimated time and costs required for generation of
(1,000 to 1,000,000) DNA sequences with TU-counting versus
pyrosequencing. * - Considering ideal bacterial densities in all
plates, allowing the recovery of 250 colonies/plate and a cost of
US$0.46/plate ** - Considering the availability of a dedicated
DNA sequencer running 3.3 plates/day, at a cost of US$3.00/
sample. *** - The time required for this step is the same for the
number of sequences given in this example or for a full 454
Titanium platform (1,00,000 reads). Cost of this step is
Next Generation Phage Display
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the DNA sequencing Core facility at The University of Texas M.
D. Anderson Cancer Center.
Found at: doi:10.1371/journal.pone.0008338.s008 (0.07 MB
DOC)
Phage Sequences File S1 All phage sequences produced by the
approach presented here are included together with the encoded
peptide and the frequency of the insert for all tissues and the non-
injected CX7C library.
Found at: doi:10.1371/journal.pone.0008338.s009 (2.5 MB
DOC)
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